NEUROCRINE BIOSCIENCES, INC. Quotes Neurocrine Biosciences, Inc. Sao Paulo
Equities
N1BI34
BRN1BIBDR009
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.68 BRL | +1.89% |
|
+0.77% | +13.56% |
Quotes 5-day view
Delayed Quote Sao Paulo| 2024-06-14 | 2024-06-17 | 2024-06-18 | 2024-06-20 | |
|---|---|---|---|---|
| Last | 36.4 R$ | 36.72 R$ | 36 R$ | 36.68 R$ |
| Volume | 3 000 | 15 | 1 | 107 |
| Change | +∞% | +0.88% | -1.96% | +1.89% |
| Opening | 36.40 | 36.72 | 36.00 | 35.92 |
| High | 36.40 | 36.72 | 36.00 | 36.68 |
| Low | 36.40 | 36.72 | 36.00 | 35.92 |
Performance
| 1 day | +1.89% | ||
| 1 week | +0.77% | ||
| Current month | +3.73% | ||
| 1 month | +1.55% | ||
| 3 months | -0.11% | ||
| 6 months | +17.45% | ||
| Current year | +13.56% | ||
| 1 year | +58.65% | ||
| 3 years | +44.35% |
Volumes
marketsDaily volume
107
Estimated daily volume
107
Avg. Volume 20 sessions
522
Daily volume ratio
0.20
Avg. Volume 20 sessions BRL
19 146.96
Avg. Volume 20 sessions USD
3 512.82
Record volume 1
12 300
Record volume 2
7 100
Record volume 3
6 000
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (BRL)
13 542 751 637
Capitalization (USD)
13 542 751 637
Net sales (USD)
1 887 100 000
Number of employees
1 448
Sales / Employee (USD)
1 303 246
Free-Float
98.2 %
Free-Float capitalization (BRL)
2 439 814 119
Free-Float capitalization (USD)
13 298 450 837
Average Daily Capital Traded
0%
Highs and lows
1 week
35.92
36.72
1 month
34.4036.72
Current year
31.6836.84
1 year
22.9236.84
3 years
19.5836.84
5 years
19.5836.84
10 years
19.5836.84
Indicators
Moving average 5 days
36.45
Moving average 20 days
35.98
Moving average 50 days
35.28
Moving average 100 days
34.87
Price spread / (MMA5)
-0.63%
Price spread / (MMA20)
-1.90%
Price spread / (MMA50)
-3.81%
Price spread / (MMA100)
-4.92%
STIM
RSI 9 days
56.60
RSI 14 days
55.48
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +1.89% | +0.77% | +13.56% | +58.65% | 13.54B | ||
| -0.57% | -2.50% | +15.19% | +34.62% | 121B | ||
| +0.84% | +1.60% | +19.91% | +35.05% | 114B | ||
| -1.44% | -8.08% | -19.80% | -21.13% | 20.43B | ||
| +0.50% | -1.45% | -16.19% | -30.65% | 16.55B | ||
| +0.37% | -3.98% | -13.45% | -16.03% | 16.45B | ||
| -1.46% | -7.35% | -44.35% | -36.03% | 15.59B | ||
| +30.14% | +30.84% | +66.67% | +29.70% | 15.19B | ||
| +5.07% | +6.37% | +119.39% | +234.27% | 10.96B | ||
| +3.00% | +2.74% | +19.33% | +38.60% | 8.15B | ||
| +4.44% | +0.38% | -29.18% | -43.19% | 7.77B | ||
| -0.07% | +0.28% | -1.77% | +24.74% | 7.59B | ||
| +5.12% | +0.16% | +1.51% | +43.86% | 7.33B | ||
| +18.62% | +15.85% | +105.65% | +178.69% | 6.85B | ||
| +1.36% | +4.14% | +39.48% | +45.50% | 6.56B | ||
| +2.16% | +2.12% | -7.46% | +11.67% | 6.47B | ||
| Average | +4.37% | +2.70% | +16.78% | +36.77% | ||
| Weighted average by Cap. | +1.96% | +0.57% | +14.93% | +31.23% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +13.56% | ||
| 2023 | +2.28% | ||
| 2022 | +33.70% | ||
| 2021 | -6.16% | ||
| 2020 | -11.68% |
- Stock Market
- Equities
- NBIX Stock
- N1BI34 Stock
- Quotes Neurocrine Biosciences, Inc.
